Dural Repair Market Analysis | United States | 2017-2023 | MedCore

Dural Repair Market Analysis | United States | 2017-2023 | MedCore


  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 526
  • Type: MedCore

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
Dural defects may be repaired either by suturing or applying a dural graft to prevent CSF leaks and facilitate healing. Occasionally, dural tears cannot be closed primarily and dural grafts must be used. Harvested autologous collagenous membrane grafts, such as the pericranium, fascia lata or temporal fascia are routinely used for repair of the dura mater. These native collagen grafts are immunologically tolerated, and reconstituted with host cells and supporting vasculature, eventually becoming completely remodeled. The biological response to autologous collagen membrane grafts in dural repair is ideal based on the fact that native tissue is used. However, sufficient quantities may not always be available, and a second skin incision is required for harvesting some tissue sources like the fascia lata. This could potentially increase the morbidity of the procedure and of course increases the total length of the surgery. Non-autologous dural repair products are alternatives to tissue being removed and grafted from another location in the patient’s body. As such, non-human animal tissue-derived dural patches (xenografts) are an increasingly common form of device used for dural repair owing to their versatility, competitive pricing and outstanding performance. This is followed by the use of grafts composed of synthetic materials (alloplasts), which regularly consist of expanded polytetrafluoroethylene (ePTFE), polyester urethane and polyglactin. This synthetic mesh is the least expensive option available, at the cost of an increased likelihood of postoperative complications. Human tissue-derived products (allografts) perform much better than synthetic products, but are used rarely in dural repair mainly due to the high cost associated with their use.

The "US Market Report Suite for Soft Tissue Reinforcement and Regeneration 2017 - MedSuite" includes analysis on the following companies currently active in this market:
C.R. Bard
Wright Medical
Integra LifeSciences
Smith & Nephew
Boston Scientific
Atrium Medical
Cook Medical
Johnson & Johnson
Soluble Systems
RTI Biologics
Zimmer Biomet
Aesculap/B. Braun
Gore Medical
Others include: Medline, MTF, WL Gore, Tutogen, Novus Scientific, Ariste Medical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

Please fill out the all of the required fields and the captcha